AMS — Advanced Medical Solutions Balance Sheet
0.000.00%
- £385.13m
- £455.39m
- £177.52m
- 76
- 23
- 44
- 42
Annual balance sheet for Advanced Medical Solutions, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 53.8 | 73 | 82.3 | 60.2 | 17 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 19.5 | 20.9 | 20.4 | 22.7 | 53.7 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 97.2 | 115 | 132 | 122 | 126 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 30.1 | 27.4 | 29 | 29.6 | 45.9 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 239 | 250 | 281 | 289 | 389 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 14.7 | 17 | 22.7 | 21.6 | 44.3 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 36.3 | 36.8 | 44.5 | 45 | 148 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 202 | 213 | 237 | 244 | 241 |
Total Liabilities & Shareholders' Equity | 239 | 250 | 281 | 289 | 389 |
Total Common Shares Outstanding |